Global Anti-amyloid-β Monoclonal Antibodies Supply, Demand and Key Producers, 2024-2030

Page: 86

Published Date: 27 Oct 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Anti-amyloid-β monoclonal antibodies are a class of targeted biologic therapies designed to bind specifically to amyloid-beta peptides in the brain, which are associated with the formation of amyloid plaques in Alzheimer's disease. By targeting these plaques, these antibodies aim to facilitate their clearance from the brain, potentially slowing the progression of neurodegeneration and improving cognitive function in patients.Examples include donanemab and lecanemab, which have been developed to treat early stages of Alzheimer's.

The global Anti-amyloid-β Monoclonal Antibodies market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

The market for anti-amyloid-β monoclonal antibodies is experiencing rapid growth, driven by the increasing prevalence of Alzheimer's disease and the recent approval of innovative therapies like donanemab and lecanemab. This surge is fueled by heightened awareness and demand for disease-modifying treatments that address the underlying pathology of Alzheimer's rather than just symptomatic relief.Challenges such as pricing, accessibility, and long-term efficacy remain, but the overall trend indicates a significant shift towards targeting amyloid pathology in Alzheimer's therapy, promising a transformative impact on patient care and market growth.

This report studies the global Anti-amyloid-β Monoclonal Antibodies production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-amyloid-β Monoclonal Antibodies and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-amyloid-β Monoclonal Antibodies that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-amyloid-β Monoclonal Antibodies total production and demand, 2019-2030, (K Units)
Global Anti-amyloid-β Monoclonal Antibodies total production value, 2019-2030, (USD Million)
Global Anti-amyloid-β Monoclonal Antibodies production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Anti-amyloid-β Monoclonal Antibodies consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Anti-amyloid-β Monoclonal Antibodies domestic production, consumption, key domestic manufacturers and share
Global Anti-amyloid-β Monoclonal Antibodies production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Anti-amyloid-β Monoclonal Antibodies production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Anti-amyloid-β Monoclonal Antibodies production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Anti-amyloid-β Monoclonal Antibodies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eisai, Biogen, Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-amyloid-β Monoclonal Antibodies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-amyloid-β Monoclonal Antibodies Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-amyloid-β Monoclonal Antibodies Market, Segmentation by Type:
    Lecanemab
    Donanemab

Global Anti-amyloid-β Monoclonal Antibodies Market, Segmentation by Application:
    Hospital
    Clinic
    Other

Companies Profiled:
    Eisai
    Biogen
    Eli Lilly

Key Questions Answered:
1. How big is the global Anti-amyloid-β Monoclonal Antibodies market?
2. What is the demand of the global Anti-amyloid-β Monoclonal Antibodies market?
3. What is the year over year growth of the global Anti-amyloid-β Monoclonal Antibodies market?
4. What is the production and production value of the global Anti-amyloid-β Monoclonal Antibodies market?
5. Who are the key producers in the global Anti-amyloid-β Monoclonal Antibodies market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Anti-amyloid-β Monoclonal Antibodies Introduction
    1.2 World Anti-amyloid-β Monoclonal Antibodies Supply & Forecast
        1.2.1 World Anti-amyloid-β Monoclonal Antibodies Production Value (2019 & 2023 & 2030)
        1.2.2 World Anti-amyloid-β Monoclonal Antibodies Production (2019-2030)
        1.2.3 World Anti-amyloid-β Monoclonal Antibodies Pricing Trends (2019-2030)
    1.3 World Anti-amyloid-β Monoclonal Antibodies Production by Region (Based on Production Site)
        1.3.1 World Anti-amyloid-β Monoclonal Antibodies Production Value by Region (2019-2030)
        1.3.2 World Anti-amyloid-β Monoclonal Antibodies Production by Region (2019-2030)
        1.3.3 World Anti-amyloid-β Monoclonal Antibodies Average Price by Region (2019-2030)
        1.3.4 North America Anti-amyloid-β Monoclonal Antibodies Production (2019-2030)
        1.3.5 Europe Anti-amyloid-β Monoclonal Antibodies Production (2019-2030)
        1.3.6 China Anti-amyloid-β Monoclonal Antibodies Production (2019-2030)
        1.3.7 Japan Anti-amyloid-β Monoclonal Antibodies Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-amyloid-β Monoclonal Antibodies Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-amyloid-β Monoclonal Antibodies Major Market Trends

2 Demand Summary
    2.1 World Anti-amyloid-β Monoclonal Antibodies Demand (2019-2030)
    2.2 World Anti-amyloid-β Monoclonal Antibodies Consumption by Region
        2.2.1 World Anti-amyloid-β Monoclonal Antibodies Consumption by Region (2019-2024)
        2.2.2 World Anti-amyloid-β Monoclonal Antibodies Consumption Forecast by Region (2025-2030)
    2.3 United States Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)
    2.4 China Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)
    2.5 Europe Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)
    2.6 Japan Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)
    2.7 South Korea Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)
    2.8 ASEAN Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)
    2.9 India Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Anti-amyloid-β Monoclonal Antibodies Production Value by Manufacturer (2019-2024)
    3.2 World Anti-amyloid-β Monoclonal Antibodies Production by Manufacturer (2019-2024)
    3.3 World Anti-amyloid-β Monoclonal Antibodies Average Price by Manufacturer (2019-2024)
    3.4 Anti-amyloid-β Monoclonal Antibodies Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Anti-amyloid-β Monoclonal Antibodies Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Anti-amyloid-β Monoclonal Antibodies in 2023
        3.5.3 Global Concentration Ratios (CR8) for Anti-amyloid-β Monoclonal Antibodies in 2023
    3.6 Anti-amyloid-β Monoclonal Antibodies Market: Overall Company Footprint Analysis
        3.6.1 Anti-amyloid-β Monoclonal Antibodies Market: Region Footprint
        3.6.2 Anti-amyloid-β Monoclonal Antibodies Market: Company Product Type Footprint
        3.6.3 Anti-amyloid-β Monoclonal Antibodies Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Value Comparison
        4.1.1 United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Comparison
        4.2.1 United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Anti-amyloid-β Monoclonal Antibodies Consumption Comparison
        4.3.1 United States VS China: Anti-amyloid-β Monoclonal Antibodies Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Anti-amyloid-β Monoclonal Antibodies Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Anti-amyloid-β Monoclonal Antibodies Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Anti-amyloid-β Monoclonal Antibodies Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production (2019-2024)
    4.5 China Based Anti-amyloid-β Monoclonal Antibodies Manufacturers and Market Share
        4.5.1 China Based Anti-amyloid-β Monoclonal Antibodies Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value (2019-2024)
        4.5.3 China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production (2019-2024)
    4.6 Rest of World Based Anti-amyloid-β Monoclonal Antibodies Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Anti-amyloid-β Monoclonal Antibodies Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-amyloid-β Monoclonal Antibodies Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Lecanemab
        5.2.2 Donanemab
    5.3 Market Segment by Type
        5.3.1 World Anti-amyloid-β Monoclonal Antibodies Production by Type (2019-2030)
        5.3.2 World Anti-amyloid-β Monoclonal Antibodies Production Value by Type (2019-2030)
        5.3.3 World Anti-amyloid-β Monoclonal Antibodies Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-amyloid-β Monoclonal Antibodies Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Anti-amyloid-β Monoclonal Antibodies Production by Application (2019-2030)
        6.3.2 World Anti-amyloid-β Monoclonal Antibodies Production Value by Application (2019-2030)
        6.3.3 World Anti-amyloid-β Monoclonal Antibodies Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Eisai
        7.1.1 Eisai Details
        7.1.2 Eisai Major Business
        7.1.3 Eisai Anti-amyloid-β Monoclonal Antibodies Product and Services
        7.1.4 Eisai Anti-amyloid-β Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Eisai Recent Developments/Updates
        7.1.6 Eisai Competitive Strengths & Weaknesses
    7.2 Biogen
        7.2.1 Biogen Details
        7.2.2 Biogen Major Business
        7.2.3 Biogen Anti-amyloid-β Monoclonal Antibodies Product and Services
        7.2.4 Biogen Anti-amyloid-β Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Biogen Recent Developments/Updates
        7.2.6 Biogen Competitive Strengths & Weaknesses
    7.3 Eli Lilly
        7.3.1 Eli Lilly Details
        7.3.2 Eli Lilly Major Business
        7.3.3 Eli Lilly Anti-amyloid-β Monoclonal Antibodies Product and Services
        7.3.4 Eli Lilly Anti-amyloid-β Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Eli Lilly Recent Developments/Updates
        7.3.6 Eli Lilly Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-amyloid-β Monoclonal Antibodies Industry Chain
    8.2 Anti-amyloid-β Monoclonal Antibodies Upstream Analysis
        8.2.1 Anti-amyloid-β Monoclonal Antibodies Core Raw Materials
        8.2.2 Main Manufacturers of Anti-amyloid-β Monoclonal Antibodies Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Anti-amyloid-β Monoclonal Antibodies Production Mode
    8.6 Anti-amyloid-β Monoclonal Antibodies Procurement Model
    8.7 Anti-amyloid-β Monoclonal Antibodies Industry Sales Model and Sales Channels
        8.7.1 Anti-amyloid-β Monoclonal Antibodies Sales Model
        8.7.2 Anti-amyloid-β Monoclonal Antibodies Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Anti-amyloid-β Monoclonal Antibodies Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Anti-amyloid-β Monoclonal Antibodies Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Anti-amyloid-β Monoclonal Antibodies Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Region (2019-2024)
 Table 5. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Region (2025-2030)
 Table 6. World Anti-amyloid-β Monoclonal Antibodies Production by Region (2019-2024) & (K Units)
 Table 7. World Anti-amyloid-β Monoclonal Antibodies Production by Region (2025-2030) & (K Units)
 Table 8. World Anti-amyloid-β Monoclonal Antibodies Production Market Share by Region (2019-2024)
 Table 9. World Anti-amyloid-β Monoclonal Antibodies Production Market Share by Region (2025-2030)
 Table 10. World Anti-amyloid-β Monoclonal Antibodies Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Anti-amyloid-β Monoclonal Antibodies Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Anti-amyloid-β Monoclonal Antibodies Major Market Trends
 Table 13. World Anti-amyloid-β Monoclonal Antibodies Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Anti-amyloid-β Monoclonal Antibodies Consumption by Region (2019-2024) & (K Units)
 Table 15. World Anti-amyloid-β Monoclonal Antibodies Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Anti-amyloid-β Monoclonal Antibodies Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Anti-amyloid-β Monoclonal Antibodies Producers in 2023
 Table 18. World Anti-amyloid-β Monoclonal Antibodies Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Anti-amyloid-β Monoclonal Antibodies Producers in 2023
 Table 20. World Anti-amyloid-β Monoclonal Antibodies Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Anti-amyloid-β Monoclonal Antibodies Company Evaluation Quadrant
 Table 22. World Anti-amyloid-β Monoclonal Antibodies Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Anti-amyloid-β Monoclonal Antibodies Production Site of Key Manufacturer
 Table 24. Anti-amyloid-β Monoclonal Antibodies Market: Company Product Type Footprint
 Table 25. Anti-amyloid-β Monoclonal Antibodies Market: Company Product Application Footprint
 Table 26. Anti-amyloid-β Monoclonal Antibodies Competitive Factors
 Table 27. Anti-amyloid-β Monoclonal Antibodies New Entrant and Capacity Expansion Plans
 Table 28. Anti-amyloid-β Monoclonal Antibodies Mergers & Acquisitions Activity
 Table 29. United States VS China Anti-amyloid-β Monoclonal Antibodies Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Anti-amyloid-β Monoclonal Antibodies Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Anti-amyloid-β Monoclonal Antibodies Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Anti-amyloid-β Monoclonal Antibodies Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Market Share (2019-2024)
 Table 37. China Based Anti-amyloid-β Monoclonal Antibodies Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Market Share (2019-2024)
 Table 42. Rest of World Based Anti-amyloid-β Monoclonal Antibodies Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Market Share (2019-2024)
 Table 47. World Anti-amyloid-β Monoclonal Antibodies Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Anti-amyloid-β Monoclonal Antibodies Production by Type (2019-2024) & (K Units)
 Table 49. World Anti-amyloid-β Monoclonal Antibodies Production by Type (2025-2030) & (K Units)
 Table 50. World Anti-amyloid-β Monoclonal Antibodies Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Anti-amyloid-β Monoclonal Antibodies Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Anti-amyloid-β Monoclonal Antibodies Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Anti-amyloid-β Monoclonal Antibodies Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Anti-amyloid-β Monoclonal Antibodies Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Anti-amyloid-β Monoclonal Antibodies Production by Application (2019-2024) & (K Units)
 Table 56. World Anti-amyloid-β Monoclonal Antibodies Production by Application (2025-2030) & (K Units)
 Table 57. World Anti-amyloid-β Monoclonal Antibodies Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Anti-amyloid-β Monoclonal Antibodies Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Anti-amyloid-β Monoclonal Antibodies Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Anti-amyloid-β Monoclonal Antibodies Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Eisai Basic Information, Manufacturing Base and Competitors
 Table 62. Eisai Major Business
 Table 63. Eisai Anti-amyloid-β Monoclonal Antibodies Product and Services
 Table 64. Eisai Anti-amyloid-β Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Eisai Recent Developments/Updates
 Table 66. Eisai Competitive Strengths & Weaknesses
 Table 67. Biogen Basic Information, Manufacturing Base and Competitors
 Table 68. Biogen Major Business
 Table 69. Biogen Anti-amyloid-β Monoclonal Antibodies Product and Services
 Table 70. Biogen Anti-amyloid-β Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Biogen Recent Developments/Updates
 Table 72. Biogen Competitive Strengths & Weaknesses
 Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 74. Eli Lilly Major Business
 Table 75. Eli Lilly Anti-amyloid-β Monoclonal Antibodies Product and Services
 Table 76. Eli Lilly Anti-amyloid-β Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Eli Lilly Recent Developments/Updates
 Table 78. Eli Lilly Competitive Strengths & Weaknesses
 Table 79. Global Key Players of Anti-amyloid-β Monoclonal Antibodies Upstream (Raw Materials)
 Table 80. Global Anti-amyloid-β Monoclonal Antibodies Typical Customers
 Table 81. Anti-amyloid-β Monoclonal Antibodies Typical Distributors


List of Figures
 Figure 1. Anti-amyloid-β Monoclonal Antibodies Picture
 Figure 2. World Anti-amyloid-β Monoclonal Antibodies Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Anti-amyloid-β Monoclonal Antibodies Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Anti-amyloid-β Monoclonal Antibodies Production (2019-2030) & (K Units)
 Figure 5. World Anti-amyloid-β Monoclonal Antibodies Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Region (2019-2030)
 Figure 7. World Anti-amyloid-β Monoclonal Antibodies Production Market Share by Region (2019-2030)
 Figure 8. North America Anti-amyloid-β Monoclonal Antibodies Production (2019-2030) & (K Units)
 Figure 9. Europe Anti-amyloid-β Monoclonal Antibodies Production (2019-2030) & (K Units)
 Figure 10. China Anti-amyloid-β Monoclonal Antibodies Production (2019-2030) & (K Units)
 Figure 11. Japan Anti-amyloid-β Monoclonal Antibodies Production (2019-2030) & (K Units)
 Figure 12. Anti-amyloid-β Monoclonal Antibodies Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 15. World Anti-amyloid-β Monoclonal Antibodies Consumption Market Share by Region (2019-2030)
 Figure 16. United States Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 17. China Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 18. Europe Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 19. Japan Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 22. India Anti-amyloid-β Monoclonal Antibodies Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Anti-amyloid-β Monoclonal Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-amyloid-β Monoclonal Antibodies Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-amyloid-β Monoclonal Antibodies Markets in 2023
 Figure 26. United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Anti-amyloid-β Monoclonal Antibodies Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Anti-amyloid-β Monoclonal Antibodies Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Market Share 2023
 Figure 30. China Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Anti-amyloid-β Monoclonal Antibodies Production Market Share 2023
 Figure 32. World Anti-amyloid-β Monoclonal Antibodies Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Type in 2023
 Figure 34. Lecanemab
 Figure 35. Donanemab
 Figure 36. World Anti-amyloid-β Monoclonal Antibodies Production Market Share by Type (2019-2030)
 Figure 37. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Type (2019-2030)
 Figure 38. World Anti-amyloid-β Monoclonal Antibodies Average Price by Type (2019-2030) & (US$/Unit)
 Figure 39. World Anti-amyloid-β Monoclonal Antibodies Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Application in 2023
 Figure 41. Hospital
 Figure 42. Clinic
 Figure 43. Other
 Figure 44. World Anti-amyloid-β Monoclonal Antibodies Production Market Share by Application (2019-2030)
 Figure 45. World Anti-amyloid-β Monoclonal Antibodies Production Value Market Share by Application (2019-2030)
 Figure 46. World Anti-amyloid-β Monoclonal Antibodies Average Price by Application (2019-2030) & (US$/Unit)
 Figure 47. Anti-amyloid-β Monoclonal Antibodies Industry Chain
 Figure 48. Anti-amyloid-β Monoclonal Antibodies Procurement Model
 Figure 49. Anti-amyloid-β Monoclonal Antibodies Sales Model
 Figure 50. Anti-amyloid-β Monoclonal Antibodies Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Eisai
Biogen
Eli Lilly

Related Reports

Global Anti-amyloid-β Monoclonal Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Anti-amyloid-β Monoclonal Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 27 Oct 2024

date Pharma & Healthcare

Anti-amyloid-β monoclonal antibodies are a class of targeted biologic therapies designed to bind specifically to amyloid-beta peptides in the brain, which are associated with the formation of amyloid plaques in Alzheimer's disease. By targeting these plaques, these antibodies aim to facilitate their clearance from the brain, potentially slowing the progression of neurodegeneration and improving cognitive function in patients.Examples include donanemab and lecanemab, which have been developed to treat early stages of Alzheimer's.

Product Tags

Anti-amyloid-β Monoclonal Antibodies

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>